Work

Atezolizumab (atezo) in patients with metastatic urothelial carcinoma (mUC): A 2-year clinical update from a phase Ia study.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.6_suppl.290

Authors: Daniel Peter Petrylak, Thomas Powles, Joaquim Bellmunt, Fadi S. Braiteh, Yohann Loriot, Rafael Morales, Howard A. Burris, Joseph W. Kim, Beiying Ding, Dannis Chang, Marcella Fasso, Carol O'Hear, Nicholas J. Vogelzang

Institutions: Yale University, Queen Mary University of London, Barts Cancer Institute, Dana-Farber Cancer Institute, The US Oncology Network, Institut Gustave Roussy, Instituto Nacional de Cancerología, Sarah Cannon, Yale Cancer Center, Genentech, Comprehensive Cancer Centers of Nevada

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601087129

Cites:

Cited by: 12

Related to: 10